|
1
|
Coussens LM and Werb Z: Inflammation and
cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Berasain C, Castillo J, Perugorria MJ,
Latasa MU, Prieto J and Avila MA: Inflammation and liver cancer:
New molecular links. Ann N Y Acad Sci. 1155:206–221. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Llovet JM, Fuster J and Bruix J; Barcelona
Clinic Liver Cancer (BCLC) Group, : Intention-to-treat analysis of
surgical treatment for early hepatocellular carcinoma: Resection
versus transplantation. Hepatology. 30:1434–1440. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Adam R, Azoulay D, Castaing D, Eshkenazy
R, Pascal G, Hashizume K, Samuel D and Bismuth H: Liver resection
as a bridge to transplantation for hepatocellular carcinoma on
cirrhosis: A reasonable strategy? Ann Surg. 238:508–518; discussion
518-519. 2003.PubMed/NCBI
|
|
5
|
Marrero JA: Multidisciplinary management
of hepatocellular carcinoma: Where are we today? Semin Liver Dis.
33 Suppl 1:S3–S10. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Livraghi T, Mäkisalo H and Line PD:
Treatment options in hepatocellular carcinoma today. Scand J Surg.
100:22–29. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mazzaferro V, Bhoori S, Sposito C, Bongini
M, Langer M, Miceli R and Mariani L: Milan criteria in liver
transplantation for hepatocellular carcinoma: An evidence-based
analysis of 15 years of experience. Liver Transpl. 17 Suppl
2:S44–S57. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273.e1. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schwartz M, Roayaie S and Konstadoulakis
M: Strategies for the management of hepatocellular carcinoma. Nat
Clin Pract Oncol. 4:424–432. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Llovet JM: Updated treatment approach to
hepatocellular carcinoma. J Gastroenterol. 40:225–235. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Poon RT-P, Fan ST, Lo CM, Liu CL and Wong
J: Long-term survival and pattern of recurrence after resection of
small hepatocellular carcinoma in patients with preserved liver
function: Implications for a strategy of salvage transplantation.
Ann Surg. 235:373–382. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yamamoto J, Kosuge T, Takayama T, Shimada
K, Yamasaki S, Ozaki H, Yamaguchi N and Makuuchi M: Recurrence of
hepatocellular carcinoma after surgery. Br J Surg. 83:1219–1222.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Imamura H, Matsuyama Y, Tanaka E, Ohkubo
T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T,
Kawasaki S, et al: Risk factors contributing to early and late
phase intrahepatic recurrence of hepatocellular carcinoma after
hepatectomy. J Hepatol. 38:200–207. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Poon RT, Fan ST, Ng IO, Lo CM, Liu CL and
Wong J: Different risk factors and prognosis for early and late
intrahepatic recurrence after resection of hepatocellular
carcinoma. Cancer. 89:500–507. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ercolani G, Grazi GL, Ravaioli M, Del
Gaudio M, Gardini A, Cescon M, Varotti G, Cetta F and Cavallari A:
Liver resection for hepatocellular carcinoma on cirrhosis:
Univariate and multivariate analysis of risk factors for
intrahepatic recurrence. Ann Surg. 237:536–543. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wahab M Abdel, Sultan A, el-Ghawalby N,
Fathy O, Abu Zeid M, Abu el-Enin A, Abdallah T, Foad A, Kandeel T,
el-Shobari M, et al: Hepatic resection in cirrhotic liver for
treatment of hepatocellular carcinoma in Egyptian patients.
Experience with 140 cases in a single center.
Hepatogastroenterology. 51:559–563. 2004.PubMed/NCBI
|
|
17
|
Kumada T, Nakano S, Takeda I, Sugiyama K,
Osada T, Kiriyama S, Sone Y, Toyoda H, Shimada S, Takahashi M, et
al: Patterns of recurrence after initial treatment in patients with
small hepatocellular carcinoma. Hepatology. 25:87–92. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Adachi E, Maeda T, Matsumata T, Shirabe K,
Kinukawa N, Sugimachi K and Tsuneyoshi M: Risk factors for
intrahepatic recurrence in human small hepatocellular carcinoma.
Gastroenterology. 108:768–775. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hoshida Y, Villanueva A, Kobayashi M, Peix
J, Chiang DY, Camargo A, Gupta S, Moore J, Wrobel MJ, Lerner J, et
al: Gene expression in fixed tissues and outcome in hepatocellular
carcinoma. N Engl J Med. 359:1995–2004. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: From genes to environment. Nat Rev Cancer.
6:674–687. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Picardo A, Karpoff HM, Ng B, Lee J,
Brennan MF and Fong Y: Partial hepatectomy accelerates local tumor
growth: Potential roles of local cytokine activation. Surgery.
124:57–64. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
de Jong KP, Lont HE, Bijma AM, Brouwers
MA, de Vries EG, van Veen ML, Marquet RL, Slooff MJ and Terpstra
OT: The effect of partial hepatectomy on tumor growth in rats: In
vivo and in vitro studies. Hepatology. 22:1263–1272. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Asaga T, Suzuki K, Umeda M, Sugimasa Y,
Takemiya S and Okamoto T: The enhancement of tumor growth after
partial hepatectomy and the effect of sera obtained from
hepatectomized rats on tumor cell growth. Jpn J Surg. 21:669–675.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lammert F, Wang DQ-H, Hillebrandt S, Geier
A, Fickert P, Trauner M, Matern S, Paigen B and Carey MC:
Spontaneous cholecysto- and hepatolithiasis in Mdr2-/− mice: A
model for low phospholipid-associated cholelithiasis. Hepatology.
39:117–128. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mauad TH, van Nieuwkerk CM, Dingemans KP,
Smit JJ, Schinkel AH, Notenboom RG, van den Bergh Weerman MA,
Verkruisen RP, Groen AK, Ou de Elferink RP, et al: Mice with
homozygous disruption of the mdr2 P-glycoprotein gene. A novel
animal model for studies of nonsuppurative inflammatory cholangitis
and hepatocarcinogenesis. Am J Pathol. 145:1237–1245.
1994.PubMed/NCBI
|
|
26
|
Barash HR, Gross E, Edrei Y, Ella E,
Israel A, Cohen I, Corchia N, Ben-Moshe T, Pappo O, Pikarsky E, et
al: Accelerated carcinogenesis following liver regeneration is
associated with chronic inflammation-induced double-strand DNA
breaks. Proc Natl Acad Sci USA. 107:2207–2212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Taub R: Liver regeneration: From myth to
mechanism. Nat Rev Mol Cell Biol. 5:836–847. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Llovet JM, Ricci S, Mazzaferro V, Hilgard
P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A,
et al: SHARP Investigators Study Group: Sorafenib in advanced
hepatocellular carcinoma. N Engl J Med. 359:378–390. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng A-L, Kang Y-K, Chen Z, Tsao CJ, Qin
S, Kim JS, Luo R, Feng J, Ye S, Yang TS, et al: Efficacy and safety
of sorafenib in patients in the Asia-Pacific region with advanced
hepatocellular carcinoma: A phase III randomised, double-blind,
placebo-controlled trial. Lancet Oncol. 10:25–34. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feng Y-X, Wang T, Deng Y-Z, Yang P, Li JJ,
Guan DX, Yao F, Zhu YQ, Qin Y, Wang H, et al: Sorafenib suppresses
postsurgical recurrence and metastasis of hepatocellular carcinoma
in an orthotopic mouse model. Hepatology. 53:483–492. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hora C, Romanque P and Dufour JFF: Effect
of sorafenib on murine liver regeneration. Hepatology. 53:577–586.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cressman DE, Greenbaum LE, DeAngelis RA,
Ciliberto G, Furth EE, Poli V and Taub R: Liver failure and
defective hepatocyte regeneration in interleukin-6-deficient mice.
Science. 274:1379–1383. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cressman DE, Diamond RH and Taub R: Rapid
activation of the Stat3 transcription complex in liver
regeneration. Hepatology. 21:1443–1449. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sansone P and Bromberg J: Targeting the
interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol.
30:1005–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zahavi T, Lanton T, Divon MS, Salmon A,
Peretz T, Galun E, Axelrod JH and Sonnenblick A: Sorafenib
treatment during partial hepatectomy reduces tumorgenesis in an
inflammation-associated liver cancer model. Oncotarget.
7:4860–4870. 2016.PubMed/NCBI
|
|
36
|
Wei AC, Tung-Ping Poon R, Fan ST and Wong
J: Risk factors for perioperative morbidity and mortality after
extended hepatectomy for hepatocellular carcinoma. Br J Surg.
90:33–41. 2003. View
Article : Google Scholar : PubMed/NCBI
|
